Actively Recruiting
Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section
Led by Tanta University · Updated on 2025-06-24
70
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block
CONDITIONS
Official Title
Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patient with ASA physical status 2 scheduled for cesarean section under spinal anesthesia
You will not qualify if you...
- Patient refusal
- ASA physical status higher than 3
- Patients with pregnancy-related diseases
- Emergency cesarean section
- History of blood clotting disorders (coagulopathy)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
tanta University hospital
Tanta, Gharbia Governorate, Egypt
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here